Jpmorgan Chase & CO Nutri Band Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NTRB
# of Institutions
16Shares Held
258KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA86.8KShares$507,7790.0% of portfolio
-
Geode Capital Management, LLC Boston, MA58.6KShares$342,6400.0% of portfolio
-
Royal Bank Of Canada Toronto, A635.1KShares$205,1010.0% of portfolio
-
State Street Corp Boston, MA17.3KShares$101,0060.0% of portfolio
-
Virtu Financial LLC New York, NY12.9KShares$75,2420.0% of portfolio
About NutriBand Inc.
- Ticker NTRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,803,260
- Market Cap $45.6M
- Description
- Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...